Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis
Johann Lechner,1 Tatjana Rudi,2 Volker von Baehr3 1Clinic for Integrative Dentistry, Munich 81547, Germany; 2Institute for Epidemiological Studies, Berlin 10709, Germany; 3Department of Immunology and Allergology, Institute for Medical Diagnostics in MVZ GbR, Berlin 12247, Germany Background: The im...
Main Authors: | Lechner J, Rudi T, von Baehr V |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | Clinical, Cosmetic and Investigational Dentistry |
Subjects: | |
Online Access: | https://www.dovepress.com/osteoimmunology-of-tumor-necrosis-factor-alpha-il-6-and-rantesccl5-a-r-peer-reviewed-article-CCIDE |
Similar Items
-
The vitamin D receptor and the etiology of RANTES/CCL-expressive fatty-degenerative osteolysis of the jawbone: an interface between osteoimmunology and bone metabolism
by: Lechner J, et al.
Published: (2018-04-01) -
Aseptic-avascular osteonecrosis: local “silent inflammation” in the jawbone and RANTES/CCL5 overexpression
by: Lechner J, et al.
Published: (2017-11-01) -
RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway
by: Loïc Maillard, et al.
Published: (2014-09-01) -
Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch–Schönlein purpura susceptibility and severity
by: Hsin-Hui Yu, et al.
Published: (2015-04-01) -
Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer
by: Lechner J, et al.
Published: (2021-04-01)